Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-31

Clinical Trial Update: The Set-Point Study: Evaluating Effects of Changing Glucose Target on Bionic Pancreas Performance [NA]

View source ↗

Summary

ACompleted clinical trial evaluating the impact of changing glucose targets on the performance of a bionic pancreas system.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Type 1 Diabetes, Type 2 Diabetes | NA | Status: COMPLETED | Results posted: 2018-08-31